Loading…
Cytomed Therapeutics Ltd Is A Pre-Clinical Biopharmaceutical Company Focused On Harnessing Its Proprietary Technologies To Create Novel Cell-Based Immunotherapies For The Treatment Of Human Cancers. The Company'S Segment Include: The Business Of Innate Immune Cell-Based Immunotherapy, Pluripotent Stem Cell-Based Therapy And Undertaking The Research And Development Of Immune Cell And Stem Cell-Based Therapy; And The Business Of Processing And Banking Of Cells Including Cord Blood Stem Cells, Research And Development On Cord Blood Derived Cell-Based Therapy. Geographically, The Company Operates In Singapore And Malaysia Which Is The Majority Revenue Generator.